Lilly (Eli) & Co.
- Book ID
- 102151188
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2004
- Weight
- 69 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1547-8335
- DOI
- 10.1002/div.1571
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Pharmaceuticals (MIC: 9.1 SIC: 2834 NAIC:325412)
Eli Lilly discovers, develops, manufactures, and sells pharmaceuticals and animal health products. Neuroscience products include Prozac®, Zyprexa®, Strattera™Darvon®, Permax®, Symbyax®and Sarafem™. Endocrine products include Humulin®, Humalog®, Humalog Mix 75/25®, Actos®, Evista®, Forteo®and Humatrope®. Oncology products include Gemzar®and Alimta®. Animal Health products include Tylan®, Rumensin®, Coban®, Monteban®, Maxiban®, Apralan®, Micotil®, Pulmotil®, Surmax®, Optaflexx®and Paylean®. Cardiovascular products, consist primarily of ReoPro®, Dobutrex®, Xigris®and Cynt®. Anti‐infective products include Ceclor®, Keflex®, Keftab®, Lorabid®, and Vancocin®, and other products.
📜 SIMILAR VOLUMES
## Abstract **Pharmaceuticals (MIC: 9.1 SIC: 2834 NAIC: 325412)** Eli Lilly is engaged primarily in the discovery, development, manufacture, and sale of pharmaceutical products. Co.'s principal products are: Neurosciences products, which includes Zyprexa®, Strattera®, Prozac®, Cymbalta® and Symbya